Morbius: Jared Leto’s Marvel film delayed again amid Omicron surge in US

‘Morbius’ was originally scheduled for release in July 2020

Trailer for ‘Morbius’

Covid-19 has delayed the release of Jared Leto’sforthcoming Marvel film Morbius for the fifth time.

On Monday (3 December), Reuters reported that the film – which was scheduled for release on 28 January this year – would now open in theatres on 1 April instead, citing an official statement from Sony Pictures.

In the Marvel superhero movie, directed by Safe House filmmaker Daniel Espinosa, Leto portrays the character of Dr Michael Morbius, a scientist who turned himself into a vampire in an attempt to cure himself from a rare blood disease.

Morbius co-stars Adria Arjona, Matt Smith, Tyrese Gibson and Jared Harris.

The film’s release, originally scheduled for July 2020, has been postponed several times due to uncertainty around the ongoing Covid-19 pandemic.

The latest decision to delay its release comes as the US is currently battling record-high Covid infections, fulled by the highly transmissible omicron variant.

In January last year, the studio announced that Morbius would open in cinemas on 18 March 2021, before announcing that fans would have to wait another seven months to watch the film.

The delay means that Morbius will no longer be the first superhero film of 2022.

Robert Pattinson is set to make his debut as Gotham City’s Dark Knight in the latest Batman film, which is currently scheduled for release on 4 March.

While promoting Spider-Man: No Way Home, star Tom Holland said he would like to see his character fight Leto’s Dr Morbius, adding that the film “looks really cool”.

The first trailer for Morbius suggested that Sony Pictures’ Universe of Marvel Characters is connected to Disney’s Marvel Cinematic Universe (MCU).

In addition to street signs calling Spider-Man a murderer, the trailer features a cameo by Michael Keaton who played The Vulture in Spider-Man: Homecoming.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in